Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders

Gene Therapy volume 13, pages 559–562 (2006)Cite this article

Abstract

The eye is a relatively isolated tissue compartment, which provides advantages for utilization of small interfering RNA (siRNA). Feasibility of using siRNA for treatment of choroidal neovascularization has been demonstrated using siRNA directed against vascular endothelial growth factor (VEGF) or VEGF receptor 1 (VEGFR1), and both of these approaches are being tested in clinical trials. The results with VEGFR1 siRNA show that VEGFR1 is proangiogenic in the eye and is not a decoy receptor as it is in developmental angiogenesis. Topical delivery of siRNAs directed against VEGF or its receptors has also been shown to suppress corneal neovascularization. Signaling through transforming growth factor-β receptor 2 (TGFβR2) has been implicated in excessive ocular scarring and TGFβR2 siRNA has shown benefit in a model relevant to excessive scarring after glaucoma filtration surgery. RNAi has been used to identify genes that promote apoptosis or oxidative damage in retinal cells and could be the basis of new treatments for glaucoma or photoreceptor degenerations. In cultured cells derived from ocular tissues, siRNA has become a valuable tool to explore the potential role of various genes in ocular disease processes. Based upon this early experience in vivo and in vitro, it appears that siRNAs may be valuable to help define the pathogenesis and develop new treatments for several ocular diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Shen J, Samul R, Lima e Silva R, Akiyama H, Liu H, Saishin Y et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Therapy [E-pub ahead of print, 29 September 2005; doi:10.1038/sj.gt.3302641].

    Article  CAS  Google Scholar 

  2. Campochiaro PA . Retinal and choroidal neovascularization. J Cell Physiol 2000; 184: 301–310.

    Article  CAS  Google Scholar 

  3. Klein R, Klein BEK, Linton KP . The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993; 137: 190–200.

    Article  CAS  Google Scholar 

  4. Klein R, Klein BEK, Moss SE, Davis MD, DeMets, DL . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520–526.

    Article  CAS  Google Scholar 

  5. Kwak N, Okamoto N, Wood JM, Campochiaro PA . VEGF is an important stimulator in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2000; 41: 3158–3164.

    CAS  Google Scholar 

  6. Saishin Y, Saishin Y, Takahashi K, Lima Silva R, Hylton D, Rudge JJWS et al. VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 2003; 195: 241–248.

    Article  CAS  Google Scholar 

  7. Kryzstolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NM et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002; 120: 338–346.

    Article  Google Scholar 

  8. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003; 9: 210–216.

    CAS  Google Scholar 

  9. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik N et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998; 153: 1641–1646.

    Article  CAS  Google Scholar 

  10. Tolentino MJ, Brucker AJ, Fosnot J, Ying GS, Wu IH, Malik G et al. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina 2004; 24: 51–56.

    Article  Google Scholar 

  11. Tolentino MJ, Brucker AJ, Fosnot J, Ying G, Wu IH, Malik G et al. Erratum. Retina 2004; 24: 660.

    Article  Google Scholar 

  12. Tolentino MJ, Brucker A, Wan S, Reich SJ, Gordon J, Duh YJ . Letter to the Editor. Retina 2004; 24: 661.

    Article  Google Scholar 

  13. Maguire M, Fine SL, Ying GS . Intravitreal injection of VEGF siRNA. Retina 2005; 25: 101–102.

    Article  Google Scholar 

  14. Oshima Y, Deering T, Oshima S, Nambu H, Reddy PS, Kaleko M et al. Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor. J Cell Physiol 2004; 199: 412–417.

    Article  CAS  Google Scholar 

  15. Oshima Y, Oshima S, Nambu H, Kachi S, Hackett SF, Melia M et al. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol 2004; 201: 393–400.

    Article  CAS  Google Scholar 

  16. Oshima Y, Oshima S, Nambu H, Kachi S, Takahashi K, Umeda N et al. Different effects of angiopoietin 2 in different vascular beds in the eye; new vessels are most sensitive. FASEB J 2005; 19: 963–965.

    Article  CAS  Google Scholar 

  17. Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes. Am J Pathol 2004; 165: 2177–2185.

    Article  CAS  Google Scholar 

  18. Park JE, Chen HH, Winer J, Houck KA, Ferrara N . Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding Flt-1 but not to Flk-1/KDR. J Biol Chem 1994; 269: 25646–25654.

    CAS  Google Scholar 

  19. Fong GH, Zhang L, Bryce DM, Peng J . Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knockout mice. Development 1999; 126: 3015–3025.

    CAS  Google Scholar 

  20. Peracchi A, Beigelman L, Usman N, Herschlag D . Rescue of abasic hammerhead ribozymes by exogenous addition of specific bases. Proc Natl Acad Sci USA 1996; 93: 11522–11527.

    Article  CAS  Google Scholar 

  21. Campochiaro PA . Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 1997; 115: 237–241.

    Article  CAS  Google Scholar 

  22. Nakamura H, Siddiqui SS, Shen X, Malik AB, Pulido JS, Kumar NM et al. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol Vis 2004; 10: 703–711.

    CAS  PubMed  Google Scholar 

  23. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ . Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neuosci 1994; 14: 4368–4374.

    Article  CAS  Google Scholar 

  24. Lingor P, Koeberle P, Kugler S, Bahr M . Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death. Brain 2005; 128: 550–558.

    Article  Google Scholar 

  25. The Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001; 119: 1417–1436.

  26. Shen J, Yan X, Dong A, Petters RM, Peng Y-W, Wong F et al. Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol 2005; 203: 457–464.

    Article  CAS  Google Scholar 

  27. Wu Z, Hackett SF, Kachi S, Rogers B, Campochiaro PA . p66shc regulates redox-sensitive NF-κB activation and oxidative stress-induced apoptosis in human RPE cells. Invest Ophthalmol Vis Sci 2005; 46: E-Abstract 1615.

  28. Cingolani C, Rogers B, Shen J, Lu L, Campochiaro PA . Intraocular injection of paraquat: a new model of oxidative damage-induced retinal degeneration. Invest Ophthalmol Vis Sci 2005; 46: E-Abstract 1599.

  29. Maeda A, Crabb JW, Palczewski K . Microsomal glutathione S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging. Biochemistry 2005; 44: 480–489.

    Article  CAS  Google Scholar 

  30. Miceli MV, Jazwinski SM . Common and cell type-specific responses of human cells to mitochondrial dysfunction. Exp Cell Res 2005; 302: 270–280.

    Article  CAS  Google Scholar 

  31. Yan RT, Wang SZ . Requirement of NeuroD for photoreceptor formation in the chick retina. Invest Ophthalmol Vis Sci 2004; 45: 48–58.

    Article  Google Scholar 

  32. Lefevre G, Glotin AL, Calipel A, Mouriaux F, Tran T, Kherrouche Z et al. Roles of stem cell factor/c-kit and effects of glivec/STI571 in human uveal melanoma cell tumorigenesis. J Biol Chem 2004; 279: 31769–31779.

    Article  CAS  Google Scholar 

  33. Choudhary S, Xiao T, Vergara LA, Srivastava S, Nees D, Piatigorsky J et al. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest Ophthalmol Vis Sci 2005; 46: 259–267.

    Article  Google Scholar 

  34. Kantorow M, Hawse JR, Cowell TL, Benhamed S, Pizarro GO, Reddy VN et al. Methionine sulfoxide reductase A is important for lens cell viability and resistance to oxidative stress. Proc Natl Acad Sci USA 2004; 101: 9654–9659.

    Article  CAS  Google Scholar 

  35. Taylor CA, Senchyna M, Flanagan J, Joyce EM, Cliche DO, Boone AN et al. Role of eIF5A in TNF-alpha-mediated apoptosis of lamina cribosa cells. Invest Ophthalmol Vis Sci 2004; 45: 3568–3576.

    Article  Google Scholar 

  36. Kakazu A, Chandrasekher G, Bazan HEP . HGF protect corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway. Invest Ophthalmol Vis Sci 2004; 45: 3485–3492.

    Article  Google Scholar 

  37. Li J, Sun XC, Bonanno JA . Role of NBC1 in apical and basolateral HCO3-permeabilities and transendothelial H CO3-fluxes in bovine corneal endothelium. Am J Physiol Cell Physiol 2004; 288: C739–C746.

    Article  Google Scholar 

  38. Fuchshofer R, Birke M, Wige-Lussen U, Kook D, Lutjen-Drecoll E . Transforming growth factor-beta2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci 2005; 46: 568–578.

    Article  Google Scholar 

  39. Li T, Lu Z, Lu L . Regulation of eye development by transcription control of CCCTC binding factor (CTCF). J Biol Chem 2004; 279: 27575–27583.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. P A Campochiaro: PAC is the George S and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience. PAC is a consultant for Sirna Therapeutics Inc., which is monitored by the Conflict of Interest Committee of the Johns Hopkins University School of Medicine.

Authors and Affiliations

  1. Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Maumenee, Baltimore, MD, USA

    P A Campochiaro

Authors
  1. P A Campochiaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P A Campochiaro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Campochiaro, P. Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther 13, 559–562 (2006). https://doi.org/10.1038/sj.gt.3302653

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302653

This article is cited by

Search

Advanced search

Quick links